Health Trials

HER2+ Advanced Breast Cancer

1

Review clinical trials related to HER2+ Advanced Breast Cancer. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Chimeric Receptor T Cells With Trastuzumab in HER2+ Advanced Breast Cancer and Other Solid Tumors

This phase Ib study aims to assess the safety and feasibility of combination of chimeric receptor T cells with trastuzumab in patients with HER2+ solid tumors, with further expansion of study population in HER2+ metastatic breast cancer once safety has been established.

Participants needed: 36
Trial details
Phase: Phase 1, Phase 2Age: 21-99Biological sex: AllType: InterventionalSponsor: National University Hospital, SingaporeUpdated: Sep 23, 2025
Eligibility criteria

Age ≥ 21 years. [+13]

Treatment within the last 30 days with any investigational drug. [+14]

Read more